Bambang Pamungkas
Jakarta, CNBC Indonesia – The Indonesian health insurance industry finds itself at a critical juncture, grappling with a looming sustainability crisis even as public awareness and demand for health coverage continue to rise. Unbridled medical inflation is rapidly eroding the resilience of the nation’s health insurance system, sparking profound concerns about the viability of current business models and the future accessibility of healthcare services. This escalating challenge is not unique to Indonesia but highlights a broader regional trend, with the archipelago identified as one of the most acutely affected by these economic pressures.
A recent report by the Global Asia Insurance Partnership (GAIP), titled "Facing Inflation and Affordability Concerns as We Reduce Protection Gaps: Sustainable Private Health Insurance in Asia," has unequivocally identified medical cost inflation as the most significant threat to healthcare financing systems across Asia. Indonesia, in particular, stands out with a projected medical inflation rate of approximately 13.6% in 2025, a figure that significantly surpasses the general inflation rate and positions the country at the pinnacle of medical cost escalation in the Asian region. This rate overshadows those of its neighbors, including Thailand at 13.1%, Malaysia at 12.5%, and Singapore at 11.5%, underscoring the severity of the challenge confronting Indonesian insurers and policymakers.
Beyond the alarming inflation figures, Indonesia faces a unique set of compounding pressures. The nation’s health insurance penetration remains notably low, alongside a stubbornly high reliance on out-of-pocket (OOP) expenditures, which currently stand at around 33%. According to data from the Financial Services Authority (OJK), these direct costs borne by individuals amounted to a staggering Rp 175 trillion, indicating that the burden of rising healthcare expenses is directly and acutely felt by the general populace. This dual challenge of limited insurance coverage and significant direct payments exacerbates the impact of medical inflation, pushing healthcare further out of reach for many and creating a volatile environment for insurance providers.
The Economic Strain on Insurers: A Looming Profitability Crisis
The surge in medical costs has had a direct and detrimental impact on the profitability of the Indonesian health insurance industry. Current data reveals a claims ratio hovering around 86%, with the combined ratio frequently breaching the 100% mark. These metrics are critical indicators of an insurer’s financial health; a claims ratio of 86% signifies that 86 cents of every dollar collected in premiums is paid out in claims. When combined with operational expenses, a combined ratio exceeding 100% means that insurers are paying out more in claims and expenses than they are collecting in premiums, effectively operating at a loss.
This unsustainable financial trajectory has already led to severe consequences within the industry. Many insurance companies are experiencing significant financial strain, with some even reporting losses in their health insurance portfolios. In extreme cases, a few players have reportedly opted to discontinue their health insurance business segments entirely, signaling a deep-seated structural issue rather than mere market fluctuations. Should this trend persist, the industry faces a grim future characterized by aggressive premium hikes, a reduction in benefit offerings, or an exodus of insurers from the market. Ultimately, this scenario would disproportionately harm the public, limiting access to essential healthcare services and placing an even greater burden on individual finances.
Unpacking the Root Causes: Flawed Product Design and Overutilization
One of the primary factors highlighted in the GAIP report as contributing to this precarious situation is the prevalence of "unhealthy" product designs within the Indonesian market. Historically, the market has been dominated by health insurance products that offer comprehensive benefits without critical cost-sharing mechanisms such as co-payments or deductibles. This model, while seemingly attractive to consumers, inadvertently fosters a culture of overutilization of healthcare services. Without any financial incentive to be prudent in their healthcare consumption, policyholders may be more inclined to seek medical attention for minor ailments, undergo unnecessary tests, or opt for more expensive treatments, all of which accelerate the rise in claims and, consequently, medical inflation.
The absence of these cost-sharing mechanisms creates a moral hazard, where the perceived "free" nature of medical services encourages excessive demand. This phenomenon places immense pressure on the financial sustainability of insurance providers, who are left to absorb the full brunt of escalating costs. The GAIP report implicitly suggests that a re-evaluation of product design, incorporating elements that encourage responsible healthcare consumption, is paramount for the long-term health of the industry.
A Regional Perspective: Lessons from Singapore and Thailand
Examining practices in other Asian countries provides valuable insights and potential pathways for Indonesia. Singapore, for instance, has successfully implemented stringent co-payment and deductible requirements within its health insurance system. This approach, coupled with a hybrid public-private healthcare model, effectively manages healthcare costs and encourages responsible utilization. Policyholders are incentivized to make informed decisions about their medical care, sharing a portion of the cost and thus mitigating the risk of overconsumption.
Thailand offers another compelling model, relying heavily on a robust universal health coverage (UHC) system. This comprehensive public health scheme has significantly reduced the direct out-of-pocket expenses for its citizens, pushing them below 10%. By providing broad-based coverage, Thailand has managed to shield its population from the immediate impact of rising medical costs, ensuring greater equity in access to healthcare.
Indonesia, in contrast, remains in a transitional phase. Its total health expenditure as a percentage of GDP is relatively low, standing at approximately 2.7%, significantly below the global average and even lower than many developing nations. Furthermore, the role of private health insurance, while growing, remains limited at around 14%. This indicates a substantial gap in comprehensive health financing, leaving a large segment of the population vulnerable to financial shocks from medical emergencies. The limited private sector involvement and the nascent stage of its universal health coverage (BPJS Kesehatan) mean that the burden of healthcare costs is often disproportionately borne by individuals.
OJK’s Proactive Stance: POJK No. 36/2025 and Ecosystem Reform
Recognizing the impending crisis, the Financial Services Authority (OJK) has taken proactive steps to reform the health insurance ecosystem in Indonesia. Through the issuance of OJK Regulation (POJK) Number 36/2025 on the Strengthening of the Health Insurance Ecosystem, the regulator aims to introduce structural changes designed to enhance sustainability and stability. Key provisions of this new regulation include:
- Mandatory Co-payment or Co-sharing: The regulation mandates the implementation of a co-payment or co-sharing mechanism, set at a minimum of 5%. This pivotal change aims to introduce a degree of financial responsibility for policyholders, thereby curbing overutilization and fostering more judicious healthcare consumption.
- Establishment of a Medical Advisory Board: The creation of a Medical Advisory Board is intended to provide expert guidance on medical claims, policy design, and best practices, ensuring a more informed and standardized approach across the industry. This board could play a crucial role in preventing fraudulent claims and ensuring that medical procedures align with established clinical guidelines.
- Implementation of Coordination Among Guarantee Providers (KAPJ): KAPJ seeks to streamline the claims process and prevent double-dipping by coordinating benefits between different insurance providers and potentially with the national health insurance scheme (BPJS Kesehatan). This aims to improve efficiency and reduce overall system costs.
This regulatory intervention by OJK is a significant step towards addressing the systemic issues plaguing the industry. By mandating co-payment and introducing other structural reforms, the OJK intends to shift the incentive structure, encouraging both insurers and policyholders to contribute to a more sustainable financing model.
GAIP’s Recommendations: A Roadmap for Sustainable Reform
While commending Indonesia’s reform efforts, GAIP offers several critical observations and recommendations to ensure the effectiveness and long-term success of POJK 36/2025:
- Inclusive Policy-Making: GAIP emphasizes the necessity of involving all relevant stakeholders, including legislators, in the policy-making process. Broad consultation ensures that regulations are comprehensive, practical, and gain wider acceptance, facilitating smoother implementation. This multi-stakeholder approach can help anticipate potential challenges and build consensus.
- Refinement of Initial Positions: The partnership suggests that continuous refinement of the initial policy framework can lead to significant beneficial progress. This implies a flexible and adaptive approach to regulation, allowing for adjustments based on market feedback and evolving circumstances.
- Offering Customer Options: GAIP recommends providing customers with a range of insurance product options. By offering choices that include co-payment structures at varying premium levels, consumers can be nudged towards more sustainable options, especially if products without co-payment become significantly more expensive. This market-driven approach allows for consumer preference while promoting cost-sharing.
- Leveraging Distribution and Renewal Processes: The report highlights that the insurance distribution and renewal processes can be powerful levers for reform. These touchpoints offer opportunities to educate policyholders about the benefits of co-payment and sustainable practices, making the reform integral to the customer journey.
GAIP unequivocally asserts that incentives are key to sustainability, and co-payment is an integral part of such an incentive structure. In an environment devoid of co-payment, high medical inflation becomes an unavoidable outcome, rendering the health insurance business unsustainable in the long run. The partnership’s analysis underscores that the decision now rests with individual insurance companies in Indonesia to determine their product pricing strategies: whether to continue offering products without co-payment or to integrate the mandated 5% co-payment.
The Industry’s Dilemma and Long-Term Implications
The choices made by Indonesian insurance companies in response to OJK’s new regulations will have profound implications for the market. If insurers continue to focus predominantly on providing products without co-payment, perhaps targeting high-income segments, GAIP warns that they are likely to perpetuate the problematic financial outcomes that currently threaten the sustainability of their health insurance portfolios. Such a strategy would essentially defer the problem, maintaining an unsustainable model that eventually leads to further market instability.
Conversely, embracing the co-payment model, even at the minimum 5% mandated by OJK, could significantly alter the trajectory of the industry. It would foster greater financial discipline among policyholders, reduce overutilization, and help stabilize claims ratios, ultimately contributing to healthier profit margins and a more sustainable business environment.
The long-term implications of this crisis and the ongoing reforms are vast. For the Indonesian healthcare system, a robust and sustainable private health insurance sector is crucial to complement the national BPJS Kesehatan program, ensuring comprehensive coverage and access to quality care for all citizens. Without a stable private sector, the burden on public healthcare resources could become overwhelming, potentially compromising the quality and availability of services.
For consumers, the outcome will determine the affordability and accessibility of health insurance. While initial premium adjustments might be necessary to reflect the true cost of coverage, a sustainable industry is ultimately in their best interest, ensuring that health insurance remains a reliable safety net rather than a fleeting promise. The crisis in Indonesia’s health insurance sector is a complex interplay of economic pressures, market dynamics, and regulatory responses. The success of OJK’s reforms, coupled with the industry’s willingness to adapt and implement GAIP’s recommendations, will be critical in navigating this challenging period and securing a sustainable future for health insurance in the archipelago. Without decisive and coordinated action, the GAIP’s warning of a potential system crisis within two to five years could become a stark reality for millions of Indonesians.
